INVO Fertility (NASDAQ:IVF) Stock Rating Upgraded by Wall Street Zen

INVO Fertility (NASDAQ:IVF) was upgraded by equities researchers at Wall Street Zen from a “sell” rating to a “hold” rating in a note issued to investors on Saturday.

Separately, Maxim Group set a $4.00 price objective on shares of INVO Fertility in a research note on Tuesday, February 10th. One investment analyst has rated the stock with a Strong Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, INVO Fertility currently has a consensus rating of “Moderate Buy” and a consensus target price of $4.00.

INVO Fertility Stock Down 2.2%

INVO Fertility stock opened at $0.85 on Friday. INVO Fertility has a 52 week low of $0.71 and a 52 week high of $103.68. The company has a market capitalization of $5.91 million, a price-to-earnings ratio of 0.00 and a beta of 2.66. The stock has a 50-day moving average price of $1.08 and a 200 day moving average price of $3.53.

Hedge Funds Weigh In On INVO Fertility

An institutional investor recently bought a new position in INVO Fertility stock. Citadel Advisors LLC bought a new position in shares of INVO Fertility, Inc (NASDAQ:IVF) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 66,849 shares of the company’s stock, valued at approximately $51,000. Citadel Advisors LLC owned 1.19% of INVO Fertility as of its most recent SEC filing. Institutional investors and hedge funds own 12.02% of the company’s stock.

About INVO Fertility

INVO Fertility (NASDAQ:IVF) is a medical technology company focused on advancing assisted reproductive treatments through innovative in-vivo incubation solutions. The company develops and commercializes devices designed to facilitate fertilization and early embryo development inside a patient’s body, offering an alternative to conventional laboratory-based in vitro fertilization (IVF) techniques.

The company’s flagship product, the INVOcell device, is a single-use, intravaginal incubator that holds a controlled microenvironment for egg and sperm co-incubation.